ARCA Biopharma Inc (NASDAQ:ABIO)

0.5579
Delayed Data
As of Apr 20
 -0.0113 / -1.99%
Today’s Change
0.45
Today|||52-Week Range
2.76
-58.67%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for ARCA Biopharma Inc have a median target of 1.75, with a high estimate of 1.75 and a low estimate of 1.75. The median estimate represents a +213.68% increase from the last price of 0.56.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in ARCA Biopharma Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
--
Sales
-$32.8B
Reporting Date
May 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
 
 
 
 
 
 
Growthannually 46.33%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.